acetylcysteine has been researched along with Intermittent Claudication in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chehuen, M; da Silva, ND; de Oliveira, EM; Fernandes, T; Forjaz, CL; Han, SW; Martin, PK; Mota, GF; Roseguini, BT; Wolosker, N | 1 |
| Miller, SJ; Unthank, JL | 1 |
1 trial(s) available for acetylcysteine and Intermittent Claudication
| Article | Year |
|---|---|
Effects of oral N-acetylcysteine on walking capacity, leg reactive hyperemia, and inflammatory and angiogenic mediators in patients with intermittent claudication.
Topics: Acetylcysteine; Administration, Oral; Aged; Antioxidants; Chemokine CCL2; Endothelins; Humans; Hyperemia; Inflammation; Intermittent Claudication; Leg; Male; MicroRNAs; Middle Aged; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Walking | 2015 |
1 other study(ies) available for acetylcysteine and Intermittent Claudication
| Article | Year |
|---|---|
Understanding the role of antioxidant therapy for intermittent claudication; good, bad, or both?
Topics: Acetylcysteine; Antioxidants; Humans; Hyperemia; Intermittent Claudication; Male; Walking | 2015 |